Dysfunctions, Molecular Mechanisms, and Therapeutic Strategies of Regulatory T Cells in Rheumatoid Arthritis

被引:10
|
作者
Li, Xiaoya [1 ,2 ]
Xu, Huihui [3 ]
Huang, Jing [4 ]
Luo, Dan [5 ]
Lv, Shuang [2 ]
Lu, Xiangchen [2 ,4 ]
Xiao, Cheng [2 ,6 ]
机构
[1] Chinese Acad Med Sci, Inst Med Plant Dev, Peking Union Med Coll, Beijing, Peoples R China
[2] China Japan Friendship Hosp, Inst Clin Med Sci, Beijing, Peoples R China
[3] China Acad Chinese Med Sci, Expt Res Ctr, Beijing Key Lab Res Chinese Med Prevent & Treatme, Beijing, Peoples R China
[4] Beijing Univ Chinese Med, Sch Tradit Chinese Med, Beijing, Peoples R China
[5] Tradit Chinese Med Hosp Changping Dist, Dept Ophthalmol, Beijing, Peoples R China
[6] China Japan Friendship Hosp, Dept Emergency, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
rheumatoid arthritis; Tregs; molecular mechanisms; dysfunctions; therapeutic strategies; ARYL-HYDROCARBON RECEPTOR; COLLAGEN-INDUCED ARTHRITIS; GROWTH-FACTOR BETA-1; FOXP3(+) TREG CELLS; DISEASE-ACTIVITY; PERIPHERAL-BLOOD; DENDRITIC CELLS; TGF-BETA; SUPPRESSIVE FUNCTION; CUTTING EDGE;
D O I
10.3389/fphar.2021.716081
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Regulatory T cells (Tregs) represent a distinct subpopulation of CD4(+) T lymphocytes that promote immune tolerance and maintain immune system homeostasis. The dysfunction of Tregs is tightly associated with rheumatoid arthritis (RA). Although the complex pathogenic processes of RA remain unclear, studies on Tregs in RA have achieved substantial progress not only in fundamental research but also in clinical application. This review discusses the current knowledge of the characterizations, functions, and molecular mechanisms of Tregs in the pathogenesis of RA, and potential therapies for these disorders are also involved.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Regulatory T cells as a biomarker for response to adalimumab in rheumatoid arthritis
    Nguyen, Dao X.
    Cotton, Alice
    Attipoe, Laura
    Ciurtin, Coziana
    Dore, Caroline J.
    Ehrenstein, Michael R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 142 (03) : 978 - +
  • [42] Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects
    Li, Chunxiao
    Jiang, Ping
    Wei, Shuhua
    Xu, Xiaofei
    Wang, Junjie
    MOLECULAR CANCER, 2020, 19 (01)
  • [43] Emerging Therapeutic Strategies for Rheumatoid Arthritis
    Gajbhiye, Kavita Rai
    Soni, Devendra Kumar
    Soni, Vandana
    CURRENT DRUG THERAPY, 2012, 7 (03) : 198 - 206
  • [44] Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects
    Chunxiao Li
    Ping Jiang
    Shuhua Wei
    Xiaofei Xu
    Junjie Wang
    Molecular Cancer, 19
  • [45] Therapeutic strategies in early rheumatoid arthritis
    Smolen, JS
    Machold, KP
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2005, 19 (01): : 163 - 177
  • [46] Altered Immunoregulation in Rheumatoid Arthritis: The Role of Regulatory T Cells and Proinflammatory Th17 Cells and Therapeutic Implications
    Alunno, Alessia
    Manetti, Mirko
    Caterbi, Sara
    Ibba-Manneschi, Lidia
    Bistoni, Onelia
    Bartoloni, Elena
    Valentini, Valentina
    Terenzi, Riccardo
    Gerli, Roberto
    MEDIATORS OF INFLAMMATION, 2015, 2015
  • [47] THERAPEUTIC REGULATION OF T-CELLS IN RHEUMATOID-ARTHRITIS
    BREEDVELD, FC
    STRUYK, L
    VANLAAR, JM
    MILTENBURG, AMM
    DEVRIES, RRP
    VANDENELSEN, PJ
    IMMUNOLOGICAL REVIEWS, 1995, 144 : 5 - 16
  • [48] Tissue retention of T cells as a therapeutic target in rheumatoid arthritis
    Syrbe, U.
    Hamann, A.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2009, 68 (08): : 678 - 682
  • [49] Distribution of regulatory T cells and interaction with dendritic cells in the synovium of rheumatoid arthritis
    E, X. Q.
    Meng, H. X.
    Cao, Y.
    Zhang, S. Q.
    Bi, Z. G.
    Yamakawa, M.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2012, 41 (06) : 413 - 420
  • [50] The role of miR-155 in regulatory T cells and rheumatoid arthritis
    Spoerl, D.
    Duroux-Richard, I.
    Louis-Plence, P.
    Jorgensen, C.
    CLINICAL IMMUNOLOGY, 2013, 148 (01) : 56 - 65